Clin Mol Hepatol.
2023 Oct;29(4):1046-1047. 10.3350/cmh.2023.0268.
Letter regarding “Risk factors in nonalcoholic fatty liver disease”
- Affiliations
-
- 1Dr D Y Patil Medical College Hospital and Research Centre, Pune, India
- KMID: 2546391
- DOI: http://doi.org/10.3350/cmh.2023.0268
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
- Prevalence of the Nonalcoholic Fatty Liver Disease in Obese Children
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
